Literature DB >> 17113860

Phage display-derived human antibodies against specific glycosaminoglycan epitopes.

Nicole C Smits1, Joost F M Lensen, Tessa J M Wijnhoven, Gerdy B Ten Dam, Guido J Jenniskens, Toin H van Kuppevelt.   

Abstract

Glycosaminoglycans (GAGs) are long unbranched polysaccharides, most of which are linked to a core protein to form proteoglycans. Depending on the nature of their backbone, one can discern galactosaminoglycans (chondroitin sulfate [CS] and dermatan sulfate [DS]) and glucosaminoglycans (heparan sulfate [HS], heparin, hyaluronic acid, and keratan sulfate). Modification of the backbone by sulfation, deacetylation, and epimerization results in unique sequences within GAG molecules, which are instrumental in the binding of a large number of proteins. Investigating the exact roles of GAGs has long been hampered by the lack of appropriate tools, but we have successfully implemented phage display technology to generate a large panel of antibodies against CS, DS, HS, and heparin epitopes. These antibodies provide unique and highly versatile tools to study the topography, structure, and function of specific GAG domains. In this chapter, we describe the selection, characterization, and application of antibodies against specific GAG epitopes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113860     DOI: 10.1016/S0076-6879(06)16005-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  21 in total

1.  SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Arie Oosterhof; Toin H van Kuppevelt; Nicole C Smits; Stephen J Kennel
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

Review 2.  Peptide-displaying phage technology in glycobiology.

Authors:  Michiko N Fukuda
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

3.  The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

Authors:  Nicole C Smits; Sindhulakshmi Kurup; Angelique L Rops; Gerdy B ten Dam; Leon F Massuger; Theo Hafmans; Jeremy E Turnbull; Dorothe Spillmann; Jin-ping Li; Stephen J Kennel; Jonathan S Wall; Nicholas W Shworak; P N Richard Dekhuijzen; Johan van der Vlag; Toin H van Kuppevelt
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 4.  The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.

Authors:  Kevin J McCarthy; Deborah J Wassenhove-McCarthy
Journal:  Microsc Microanal       Date:  2012-02       Impact factor: 4.127

5.  A transgenic approach to live imaging of heparan sulfate modification patterns.

Authors:  Matthew Attreed; Hannes E Bülow
Journal:  Methods Mol Biol       Date:  2015

6.  Imaging Glycosaminoglycan Modification Patterns In Vivo.

Authors:  Hannes E Bülow
Journal:  Methods Mol Biol       Date:  2022

7.  Conservation of anatomically restricted glycosaminoglycan structures in divergent nematode species.

Authors:  Matthew Attreed; Kristian Saied-Santiago; Hannes E Bülow
Journal:  Glycobiology       Date:  2016-03-13       Impact factor: 4.313

8.  Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.

Authors:  Audrey Deligny; Agnès Denys; Adeline Marcant; Aurélie Melchior; Joël Mazurier; Toin H van Kuppevelt; Fabrice Allain
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

9.  Generation and characterization of a series of monoclonal antibodies that specifically recognize [HexA(+/-2S)-GlcNAc]n epitopes in heparan sulfate.

Authors:  Kiyoshi Suzuki; Koji Yamamoto; Yutaka Kariya; Hiroshi Maeda; Takeshi Ishimaru; Shuichi Miyaura; Masahiro Fujii; Akiko Yusa; Eun Ji Joo; Koji Kimata; Reiji Kannagi; Yeong Shik Kim; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2008-05-07       Impact factor: 2.916

10.  Nanometer- and submicrometer-sized hollow spheres of chondroitin sulfate as a potential formulation strategy for anti-inflammatory encapsulation.

Authors:  Adriano V Reis; Marcos R Guilherme; Luiz H C Mattoso; Adley F Rubira; Elias B Tambourgi; Edvani C Muniz
Journal:  Pharm Res       Date:  2008-11-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.